Prosecution Insights
Last updated: August 18, 2026

Examiner: SAEED, ALI S

Tech Center 1600 • Art Units: 1600 1615 1616

This examiner grants 31% of resolved cases

Performance Statistics

31.2%
Allow Rate
-28.8% vs TC avg
199
Total Applications
+34.3%
Interview Lift
1470
Avg Prosecution Days
Based on 125 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
8.1%
§102 Novelty
45.3%
§103 Obviousness
24.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18723084 TRIAZINE HERBICIDAL COMPOUNDS Non-Final OA SYNGENTA CROP PROTECTION AG
18577424 Herbicidal Compositions Final Rejection SYNGENTA CROP PROTECTION AG
18551255 CYCLOBUTRIFLURAM SUSPENSION CONCENTRATE COMPOSITION Non-Final OA SYNGENTA CROP PROTECTION AG
18550876 CYCLOBUTRIFLURAM SUSPENSION CONCENTRATE COMPOSITION Non-Final OA SYNGENTA CROP PROTECTION AG
19372848 METHODS FOR MAKING L-GLUFOSINATE Final Rejection BASF SE
19258402 METHODS FOR MAKING L-GLUFOSINATE Final Rejection BASF SE
18686170 HERBICIDAL MALONAMIDES CONTAINING MONOCYCLIC HETEROAROMATIC RINGS Non-Final OA BASF SE
17261401 HERBICIDAL MIXTURES COMPRISING ISOXAFLUTOLE, SAFLUFENACIL AND AN IMIDAZOLINONE HERBICIDE; AND THEIR USE IN SOYBEAN AND COTTON CULTURES Final Rejection BASF SE
16465346 BASIC CORE MATERIAL ENCAPSULATED IN AN INORGANIC SHELL SUITABLE FOR USE IN BIOLOGICAL CARRIER MATERIALS Non-Final OA Solventum Intellectual Properties Company
15766586 STABLE PROTEIN COMPOSITIONS Non-Final OA Regeneron Pharmaceuticals, Inc.
18561432 USE OF QUASSIA-EXTRACT FOR A SEED TREATMENT AS INSECTICIDE Non-Final OA KWS SAAT SE & Co. KGaA
18162387 COMPOSITIONS AND METHODS FOR SUSTAINED OXYGEN RELEASE TO ISCHEMIC TISSUES Final Rejection Washington University
18696308 Drug Coatings for Medical Devices Non-Final OA Bard Peripheral Vascular, Inc.
18354140 COSMETIC COMPOSITION Non-Final OA AJINOMOTO CO., INC.
18376519 METHOD OF CONTROLLING FUNGAL INFECTIONS IN PLANTS Non-Final OA The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
18684580 THERAPEUTIC AGENTS TARGETING THE LYMPHATIC SYSTEM Non-Final OA VIVASOR, INC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month